BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 1085 | Download: 1143
 |
Received |
|
2013-06-06 08:52 |
 |
Peer-Review Started |
|
2013-06-07 19:10 |
 |
To Make the First Decision |
|
2013-07-19 08:49 |
 |
Return for Revision |
|
2013-07-22 18:16 |
 |
Revised |
|
2013-07-31 23:47 |
 |
Second Decision |
|
2013-08-19 12:28 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-08-20 00:25 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-10-13 20:47 |
 |
Publish the Manuscript Online |
|
2013-11-13 08:37 |
Category |
Pathology |
Manuscript Type |
Case Report |
Article Title |
Angiotensin-Ⅱ inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jennifer A Nielsen, Anita Steephen and Matthew Lewin |
Funding Agency and Grant Number |
|
Corresponding Author |
Matthew Lewin, MD, Division of Gastrointestinal Pathology, ProPath Laboratory, 1355 River Bend Dr., Dallas, TX 75247, United States. matthew.lewin@propath.com |
Key Words |
Collagenous sprue; Celiac disease; Olmesartan; Patient-drug interaction; Duodenum |
Core Tip |
Collagenous sprue (CS) is a pattern of small-bowel injury characterized histologically by marked villous blunting, intraepithelial lymphocytes, and thickened sub-epithelial collagen table. Clinically, patients present with diarrhea, abdominal pain, malabsorption, and weight loss, which raises suspicion of celiac disease. Clinicians should be aware of the possibility of drug-induced CS and potential reversibility after discontinuation of medication. |
Publish Date |
2013-11-13 08:37 |
Citation |
Nielsen JA, Steephen A, Lewin M. Angiotensin-Ⅱ inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol 2013; 19(40): 6928-6930 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i40/6928.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i40.6928 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345